> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on Drug Development for Vitiligo
- URL: https://www.fdaweb.com/meeting-on-drug-development-for-vitiligo/
- Published: 2020-02-11T12:00:00.000Z
- Updated: 2026-09-14T16:02:39.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146058

*Federal Register* notice: FDA has announced a 3/30 public meeting entitled “Patient-Focused Drug Development for Vitiligo.” The meeting is intended for FDA to obtain patient perspectives on the impact of vitiligo on daily life, patient views on treatment approaches, and decision factors considered when selecting a treatment. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2020-02767.pdf?ref=fdaweb.com).